Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 9, 2014, Pages 3520-3525

  Root, Elisabeth Dowling ^a   Lucero, Marilla ^b   Nohynek, Hanna ^c   Anthamatten, Peter ^d   Thomas, Deborah S K ^d   Tallo, Veronica ^b   Tanskanen, Antti ^c,e   Quiambao, Beatriz P ^b   Puumalainen, Taneli ^f   Lupisan, Socorro P ^b   Ruutu, Petri ^c   Ladesma, Erma ^b   Williams, Gail M ^g   Riley, Ian ^g   Simoes, Eric A F ^h  

^a UNIVERSITY OF COLORADO   (United States)

^b RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF COLORADO   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Sosiaali ja terveysministerio   (Finland)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h Nutrition Obesity Research Center at the University of Colorado   (United States)

Author keywords

GIS; Randomized controlled trial; Spatial analysis; Spatial epidemiology; Targeted intervention

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CHILD; DRUG EFFICACY; FILIPINO; GEOGRAPHIC INFORMATION SYSTEM; HEALTH CARE ACCESS; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; PHILIPPINES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RURAL AREA; STREPTOCOCCUS PNEUMONIA; VACCINATION;

GIS; RANDOMIZED CONTROLLED TRIAL; SPATIAL ANALYSIS; SPATIAL EPIDEMIOLOGY; TARGETED INTERVENTION;

GEOGRAPHIC INFORMATION SYSTEMS; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; MASS VACCINATION; PHILIPPINES; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; REGRESSION ANALYSIS; RURAL POPULATION;

EID: 84895780657     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1313748111     Document Type: Article

References (27)

1. Liu L, et al.; Child Health Epidemiology Reference Group of WHO and UNICEF (2012) Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 379(9832):2151-2161.
2. Lozano R, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095-2128.
3. Madhi SA, et al. (2013) The burden of childhood pneumonia in the developed world: A review of the literature. Pediatr Infect Dis J 32(3):e119-e127.
4. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H (2008) Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86(5):408-416.
5. Nair H, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 375(9725):1545-1555.
6. O'Brien KL, et al.; Hib and Pneumococcal Global Burden of Disease Study Team (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet 374(9693):893-902.
7. Klugman KP, et al.; Vaccine Trialists Group (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349(14):1341-1348.
8. Cutts FT, et al.; Gambian Pneumococcal Vaccine Trial Group (2005) Efficacy of ninevalent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: Randomised, double-blind, placebo-controlled trial. Lancet 365(9465):1139-1146.
9. Lucero MG, et al. (2009) Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: A randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 28(6):455-462.
10. Tregnaghi M, et al. (2011) Evaluating the Efficacy of 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (PHID-CV) Against Community-Acquired Pneumonia in Latin America in (European Society for Pediatric Infectious Diseases, The Hague, The Netherlands).
11. WHO (2012) Pneumococcal vaccines WHO position paper-2012. Wkly Epidemiol Rec 87(14):129-144.
12. Usuf E, et al. (2012) The costs of introducing pneumococcal conjugate vaccine into The Gambian immunisation programme. The 8th International Symposium on Pneumococci and Pneumococcal Diseases (Iguaçu Falls, Brazil). Available at www2.kenes.com/ISPPD/Scientific/Documents/FinalAbstractbook.pdf. Accessed June 17, 2013 (abstr).
13. Ali M, et al. (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: A reanalysis. Lancet 366(9479):44-49.
14. Emch M, et al. (2006) Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: Evidence for herd immunity. Int J Epidemiol 35(4):1044-1050.
15. Kiwanuka SN, et al. (2008) Access to and utilisation of health services for the poor in Uganda: A systematic review of available evidence. Trans R Soc Trop Med Hyg 102(11):1067-1074.
16. Peters DH, et al. (2008) Poverty and access to health care in developing countries. Ann N Y Acad Sci 1136:161-171.
17. Rutherford ME, Mulholland K, Hill PC (2010) How access to health care relates to under-five mortality in sub-Saharan Africa: Systematic review. Trop Med Int Health 15(5):508-519.
18. Schuurman N, Bell N, Dunn JR, Oliver L (2007) Deprivation indices, population health and geography: An evaluation of the spatial effectiveness of indices at multiple scales. J Urban Health 84(4):591-603.
19. Diez Roux AV, Mair C (2010) Neighborhoods and health. Ann N Y Acad Sci 1186(1): 125-145.
20. Levine OS, et al. (2011) The future of immunisation policy, implementation, and financing. Lancet 378(9789):439-448.
21. Levine OS, et al. (2010) Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: Evidence, policies, and introductions. Curr Opin Infect Dis 23(3):236-241.
22. GAVI Alliance (2013) Pneumococcal AMC. Available at www.gavialliance.org/ funding/pneumococcal-amc. Accessed December 15, 2013.
23. IMF (2007) The Gambia: Poverty Reduction Strategy Paper. IMF Country Report No. 07/308 (International Monetary Fund, Washington, DC).
24. Tanskanen A, et al.; ARIVAC Consortium (2012) Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial. BMC Res Notes 5:51.
25. Emch M, et al. (2007) Efficacy calculation in randomized trials: Global or local measures? Health Place 13(1):238-248.
26. Waller LA, Gotway CA (2004) Applied Spatial Statistics for Public Health Data (John Wiley & Sons, Hoboken, NJ).
27. Anselin L, Florax R (1995) Small sample properties of tests for spatial dependence in regression models: Some further results. New Directions in Spatial Econometrics, eds Anselin L, Florax R (Springer, New York), pp 75-95.